Wake N - Search Results

1

"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".

Seckl MJ, Savage PM, Hancock BW, Berkowitz RS, Goldstein DP, Lurain JR, Schink JC, Cagayan FM, Golfier F, Ngan H, Wake N, Osborne R, Sasaki S, Charry RC, Wong LC, Sekharan PK, Djamhoer MA, Massuger L, Belfort P, Kim SJ, Lee C, Jung SG. Seckl MJ, et al. Among authors: wake n. Gynecol Oncol. 2010 Jun;117(3):505-6; author reply 506-7. doi: 10.1016/j.ygyno.2010.01.016. Epub 2010 Feb 23. Gynecol Oncol. 2010. PMID: 20181383 No abstract available.

2

Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markers.

Shahib N, Martaadisoebrata D, Kondo H, Zhou Y, Shinkai N, Nishimura C, Kiyoko K, Matsuda T, Wake N, Kato HD. Shahib N, et al. Among authors: wake n. Gynecol Oncol. 2001 May;81(2):247-53. doi: 10.1006/gyno.2001.6145. Gynecol Oncol. 2001. PMID: 11330958

3

Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.

Kaneki E, Kobayashi H, Hirakawa T, Matsuda T, Kato H, Wake N. Kaneki E, et al. Among authors: wake n. Cancer Sci. 2010 Jul;101(7):1717-21. doi: 10.1111/j.1349-7006.2010.01602.x. Epub 2010 Apr 23. Cancer Sci. 2010. PMID: 20518791 Free article.

4

Genetics and molecular markers in gestational trophoblastic disease with special reference to their clinical application.

Matsuda T, Wake N. Matsuda T, et al. Among authors: wake n. Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):827-36. doi: 10.1016/s1521-6934(03)00096-8. Best Pract Res Clin Obstet Gynaecol. 2003. PMID: 14614883 Review.

5

Gestational choriocarcinoma whose responsible pregnancy was a complete hydatidiform mole identified by PCR analysis with new sequence tagged site primers.

Kaneta Y, Yoshiyama R, Inagaki N, Toyoshima K, Ito K, Nishino R, Kitai H, Kato H, Asanoma K, Wake N. Kaneta Y, et al. Among authors: wake n. Jpn J Clin Oncol. 1999 Oct;29(10):504-8. doi: 10.1093/jjco/29.10.504. Jpn J Clin Oncol. 1999. PMID: 10645807

6

Differential diagnosis between complete and partial mole using a TSSC3 antibody: correlation with DNA polymorphic marker analysis.

Kato H, Wake N. Kato H, et al. Among authors: wake n. J Reprod Med. 2006 Nov;51(11):861-7. J Reprod Med. 2006. PMID: 17165430

7

The propensity to malignancy of dispermic heterozygous moles.

Wake N, Fujino T, Hoshi S, Shinkai N, Sakai K, Kato H, Hashimoto M, Yasuda T, Yamada H, Ichinoe K. Wake N, et al. Placenta. 1987 May-Jun;8(3):319-26. doi: 10.1016/0143-4004(87)90056-7. Placenta. 1987. PMID: 2821529

8

Methotrexate-resistant mechanisms in human choriocarcinoma cells.

Sakai K, Wake N, Fujino T, Yasuda T, Kato H, Fujimoto S, Fujinaga K. Sakai K, et al. Among authors: wake n. Gynecol Oncol. 1989 Jul;34(1):7-11. doi: 10.1016/0090-8258(89)90095-4. Gynecol Oncol. 1989. PMID: 2737530

9

Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis.

Kato HD, Kondoh H, Inoue T, Asanoma K, Matsuda T, Arima T, Kato K, Yoshikawa T, Wake N. Kato HD, et al. Among authors: wake n. Gynecol Oncol. 2004 Nov;95(2):281-9. doi: 10.1016/j.ygyno.2004.07.050. Gynecol Oncol. 2004. PMID: 15491747

10

Involvement of IGF2 and H19 imprinting in choriocarcinoma development.

Wake N, Arima T, Matsuda T. Wake N, et al. Int J Gynaecol Obstet. 1998 Apr;60 Suppl 1:S1-8. Int J Gynaecol Obstet. 1998. PMID: 9833609 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page